Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 101 resources
-
HCV Action and Public Health England hepatitis C good practice roadshow, West London: Presentations
On 27th September 2019, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow with the West London ODN. The event featured presentations on progress in tackling hepatitis C, nationally and locally, and examples of best practice in the prevention, diagnosis, testing and treatment of hepatitis C.UK, England, Greater London 07 Oct 2019 Training, Strategy & Planning PDF -
Public Health England Hepatitis C in the UK 2019 Report
Public Health England published its annual 'Hepatitis C in the UK' report on 13th September 2019. This is the key national reporting document for hepatitis C and monitors the UK's progress towards its goal of eliminating the virus by 2030. This year's report finds that although fewer people are living with chronic hepatitis C than in previous years, the proportion of these people who do not know they are infected has increased to two-thirds (up from half).UK Reports & Research, Strategy & Planning PDF -
Scotland’s Hepatitis C Action Plan: Achievements of the First Decade and Proposals for a Scottish Government Strategy (2019) for the Elimination of both Infection and Disease
This report reflects on how the Scottish Government's Hepatitis C Action Plan was established and what it has achieved a decade after its launch. It also reflects on changing Government policy over this time and sets out future policy to achieve the elimination of hepatitis C.Scotland 31 Jul 2019 Reports & Research, Strategy & Planning PDF -
HCV Action & BVHG National Hepatitis C ODN Stakeholder Event: Presentations
On Thursday 4th July, HCV Action held a National Hepatitis C ODN Stakeholder Event, in partnership with the British Viral Hepatitis Group. The event - HCV Action's biggest to date - brought ODN representatives together to discuss the opportunities and challenges associated with the recently-announced NHS England elimination deal.England 30 Jul 2019 Training, Reports & Research, Strategy & Planning PDF -
Summary report: National Hepatitis C ODN Stakeholder Event
This report provides a summary of the the breakout sessions held during the HCV Action & British Viral Hepatitis Group National Hepatitis C ODN Stakeholder Event, which took place at the University of Warwick on 4th July 2019. The breakout sessions were held in two parts, the first focusing on problem identification and the second on identifying solutions, and focused on the following topics: community outreach; reaching ethnic minority groups; treating in prisons; and engaging with local commissioners & other partners.England 30 Jul 2019 Training, Reports & Research, Strategy & Planning PDF -
EMCDDA on models of care for hepatitis C in drugs services
The European Monitoring Centre for Drugs and Drug Addiction published 'Hepatitis C: new models of care for drugs services' in July 2019. This aims to highlight the importance of targeting people who inject drugs as a key population for the elimination of hepatitis C in Europe and to show innovative practice in the form of 11 case studies (three of which are from England). The report provides key insights into the results, impact, sustainability and transferability of each practice to guide the implementation of these new models of care in other countries and settings.UK, Rest of World, England, Greater London 29 Jul 2019 Reports & Research, Strategy & Planning PDF -
Hepatitis C: Progress towards achieving elimination in Wales
Following an inquiry into hepatitis C, the Welsh Assembly Health, Social Care and Sport Committee published this report. The report makes four main recommendations to the Welsh Government: that the Welsh Government produces a comprehensive national elimination strategy for hepatitis C, with clear ambitious targets, and workforce planning built in, and provides sustainable funding until elimination is achieved; implementation of a targeted awareness raising campaign to reach out to at risk communities; to write to Local Health BoardWales 27 Jun 2019 Reports & Research, Strategy & Planning PDF -
WHO progress report on HIV, viral hepatitis and STIs 2019
The World Health Organisation has published its mid-term report on progress towards implementing the 'Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections'. The UK signed up to the 'Global health sector strategy on viral hepatitis 2016-21', committing to eliminating hepatitis C by 2030. The report highlights the need to strengthen data and update hepatitis data more regularly. It states that global targets for reducing mortality from viral hepatitis will not be met 'without massively accelerating universal access to testing' and treatment.Rest of World 24 May 2019 Reports & Research, Strategy & Planning PDF -
WHO policy brief on access to testing and treatment for people who inject drugs and people in prisons
The World Health Organisation (WHO) published this policy brief in April 2019 to set out the current landscape of country hepatitis policies for harm reduction and hepatitis C testing and treatment for people who inject drugs and people in prisons. It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis 2016-2021, which the UK Government has signed up to, in national plans. It also provides a summary of the enablers and barriers to hepatitis C testing and treatment in these populations.UK, Rest of World 17 May 2019 Reports & Research, Tools & Templates, Strategy & Planning PDF -
Hepatitis C in England 2019 report
Public Health England's annual report on the UK’s progress towards eliminating hepatitis C sets out that although a lot has been achieved towards the World Health Organisation’s target of eliminating hepatitis C as a major public health threat by 2030, there is still much to do. In particular, the report calls for a 'radical change' in the health service's approach to hepatitis C among people who inject drugs.UK 09 Apr 2019 Reports & Research, Strategy & Planning PDF